Danish educational materials

02 February 2023

From November 15th 2016 the Danish Medicines Agency published Danish educational materials for human medicinal products approved via the national procedure, the mutual recognition procedure and the decentralised procedure.

From January 1st 2023 and forward – and not retroactively - the Danish Medicines Agency also publishes Danish educational materials for human medicinal products approved via the centralised procedure.

The marketing authorisation holder has the overall responsibility for the educational material and for ensuring that it complies with the conditions of the marketing authorisation. The marketing authorisation holder also has the overall responsibility for ensuring that the Danish Medicines Agency has the latest accepted written educational material available for publication.

Please refer to the section Dansk uddannelsesmateriale for the accepted and published Danish educational materials 

Name Medicine Type Strength Active substance Mft owner Publish Date
RINVOQ depottabletter 15 mg Upadacitinibhemihydrat AbbVie Deutschland GmbH & Co. KG 10/11/2023
RINVOQ depottabletter 30 mg Upadacitinibhemihydrat AbbVie Deutschland GmbH & Co. KG 10/11/2023
RINVOQ depottabletter 45 mg Upadacitinibhemihydrat AbbVie Deutschland GmbH & Co. KG 08/05/2023
Rivaroxaban "Hexal" filmovertrukne tabletter 2,5 mg Rivaroxaban Hexal A/S 12/08/2024
Rivaroxaban "Hexal" filmovertrukne tabletter 10 mg Rivaroxaban Hexal A/S 12/08/2024
Rivaroxaban "Hexal" filmovertrukne tabletter 15 mg Rivaroxaban Hexal A/S 12/08/2024
Rivaroxaban "Hexal" filmovertrukne tabletter 20 mg Rivaroxaban Hexal A/S 12/08/2024
Rivaroxaban "Hexal" Startpakke filmovertrukne tabletter 15+20 mg Rivaroxaban Hexal A/S 12/08/2024
Rivaroxaban "Krka" filmovertrukne tabletter 2,5 mg Rivaroxaban KRKA d.d. Novo mesto 12/03/2024
Rivaroxaban "Krka" filmovertrukne tabletter 10 mg Rivaroxaban KRKA d.d. Novo mesto 12/03/2024
Rivaroxaban "Krka" filmovertrukne tabletter 15 mg Rivaroxaban KRKA d.d. Novo mesto 12/03/2024
Rivaroxaban "Krka" filmovertrukne tabletter 20 mg Rivaroxaban KRKA d.d. Novo mesto 12/03/2024
Rivaroxaban "Sandoz" filmovertrukne tabletter 20 mg Rivaroxaban Sandoz A/S 12/08/2024
Rivaroxaban "Sandoz" filmovertrukne tabletter 15 mg Rivaroxaban Sandoz A/S 12/08/2024
Rivaroxaban "Sandoz" filmovertrukne tabletter 2,5 mg Rivaroxaban Sandoz A/S 12/08/2024
Rivaroxaban "Sandoz" filmovertrukne tabletter 10 mg Rivaroxaban Sandoz A/S 12/08/2024
Rivaroxaban "Stada" filmovertrukne tabletter 20 mg Rivaroxaban STADA Arzneimittel AG 02/04/2024
Rivaroxaban "Stada" filmovertrukne tabletter 2,5 mg Rivaroxaban STADA Arzneimittel AG 04/03/2024
Rivaroxaban "Stada" filmovertrukne tabletter 10 mg Rivaroxaban STADA Arzneimittel AG 04/03/2024
Rivaroxaban "Stada" filmovertrukne tabletter 15 mg Rivaroxaban STADA Arzneimittel AG 04/03/2024
Rivaroxaban "Stada" kapsler, hårde 15 mg Rivaroxaban STADA Arzneimittel AG 04/03/2024
Rivaroxaban "Stada" kapsler, hårde 20 mg Rivaroxaban STADA Arzneimittel AG 04/03/2024
Rivaroxaban "Stada" Startpakke filmovertrukne tabletter 15+20 mg Rivaroxaban STADA Arzneimittel AG 04/03/2024
Rivaroxaban "Stada" Startpakke kapsler, hårde 15+20 mg Rivaroxaban STADA Arzneimittel AG 04/03/2024
Rivaroxaban "Teva" filmovertrukne tabletter 2,5 mg Rivaroxaban Teva GmbH 29/04/2024
Rivaroxaban "Teva" filmovertrukne tabletter 10 mg Rivaroxaban Teva GmbH 29/04/2024
Rivaroxaban "Teva" filmovertrukne tabletter 15 mg Rivaroxaban Teva GmbH 29/04/2024
Rivaroxaban "Teva" filmovertrukne tabletter 20 mg Rivaroxaban Teva GmbH 29/04/2024
Rivaroxaban "Tillomed" filmovertrukne tabletter 10 mg Rivaroxaban Tillomed Pharma GmbH 09/10/2024
Rivaroxaban "Tillomed" filmovertrukne tabletter 2,5 mg Rivaroxaban Tillomed Pharma GmbH 09/10/2024
Rivaroxaban "Tillomed" filmovertrukne tabletter 15 mg Rivaroxaban Tillomed Pharma GmbH 09/10/2024
Rivaroxaban "Tillomed" filmovertrukne tabletter 20 mg Rivaroxaban Tillomed Pharma GmbH 09/10/2024
Rivaroxaban "Tillomed" Startpakke filmovertrukne tabletter 15 mg+20 mg Rivaroxaban Tillomed Pharma GmbH 09/10/2024
Rivaroxaban Accord filmovertrukne tabletter 2,5 mg Rivaroxaban Accord Healthcare S.L.U. 12/08/2024
Rivaroxaban Accord filmovertrukne tabletter 10 mg Rivaroxaban Accord Healthcare S.L.U. 12/08/2024
Rivaroxaban Accord filmovertrukne tabletter 15 mg Rivaroxaban Accord Healthcare S.L.U. 12/08/2024
Rivaroxaban Accord filmovertrukne tabletter 20 mg Rivaroxaban Accord Healthcare S.L.U. 12/08/2024
Rivaroxaban Accord Startpakke filmovertrukne tabletter 15 mg + 20 mg Rivaroxaban Accord Healthcare S.L.U. 12/08/2024
Rivaroxaban Viatris filmovertrukne tabletter 2,5 mg Rivaroxaban Viatris Limited 19/03/2024
Rivaroxaban Viatris filmovertrukne tabletter 10 mg Rivaroxaban Viatris Limited 19/03/2024
Rivaroxaban Viatris filmovertrukne tabletter 15 mg Rivaroxaban Viatris Limited 19/03/2024
Rivaroxaban Viatris filmovertrukne tabletter 20 mg Rivaroxaban Viatris Limited 19/03/2024
Rivaroxaban Viatris Startpakke filmovertrukne tabletter 15 mg + 20 mg Rivaroxaban Viatris Limited 19/03/2024
Rivastor depotplastre 4,6 mg/24 timer RIVASTIGMIN Orion Corporation 14/08/2020
Rivastor depotplastre 9,5 mg/24 timer RIVASTIGMIN Orion Corporation 14/08/2020
Rivastor depotplastre 13,3 mg/24 timer RIVASTIGMIN Orion Corporation 14/08/2020
Rivaxa filmovertrukne tabletter 2,5 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08/05/2024
Rivaxa filmovertrukne tabletter 10 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08/05/2024
Rivaxa filmovertrukne tabletter 15 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08/05/2024
Rivaxa filmovertrukne tabletter 20 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08/05/2024
Rivaxa Startpakke filmovertrukne tabletter 15+20 mg Rivaroxaban Glenmark Pharmaceuticals Nordic AB 08/05/2024